SHILPAMED — Shilpa Medicare Income Statement
0.000.00%
- IN₹184.31bn
- IN₹189.99bn
- IN₹15.39bn
Annual income statement for Shilpa Medicare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11,455 | 10,501 | 11,516 | 12,864 | 15,389 |
| Cost of Revenue | |||||
| Gross Profit | 6,961 | 5,630 | 6,779 | 8,079 | 10,041 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10,179 | 10,571 | 10,178 | 11,233 | 13,024 |
| Operating Profit | 1,276 | -69.6 | 1,338 | 1,631 | 2,365 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,023 | -383 | 543 | 1,223 | 2,953 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 606 | -309 | 320 | 783 | 2,433 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 607 | -325 | 319 | 783 | 2,433 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 607 | -325 | 319 | 783 | 2,433 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.38 | -1.86 | 1.61 | 5.03 | 13.3 |
| Dividends per Share |